The pathomechanisms underlying Parkinson's disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2014-01-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1586/14737175.2014.877842PMID 24471711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Neurobiology of Non-Motor Symptoms in Parkinson Disease

  2014cited by this paper
• Parkinson’s Disease Rigidity: Relation to Brain Connectivity and Motor Performance

  2013cited by this paper
• Neurodegenerative changes initiated by presynaptic dysfunction

  2013cited by this paper
• Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia.

  2013cited by this paper
• Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.

  2013cited by this paper
• Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

  2013cited by this paper
• A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.

  2013cited by this paper
• Emerging Drugs and Targets for Parkinson's Disease

  2013cited by this paper
• α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

  2013cited by this paper
• Pain in Parkinson disease: a review of the literature.

  2013cited by this paper
• Freezing of Gait in Parkinson’s Disease: Where Are We Now?

  2013cited by this paper
• Submandibular gland biopsy for the diagnosis of Parkinson disease.

  2013cited by this paper
• How pain arises in Parkinson's disease?

  2013cited by this paper
• Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

  2013cited by this paper
• Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice

  2013cited by this paper
• Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease.

  2013cited by this paper
• The cerebellum in Parkinson’s disease

  2013cited by this paper
• CHAPTER 8:Synuclein and Parkinson’s Disease: An Update

  2013cited by this paper
• Direct detection of alpha synuclein oligomers in vivo

  2013cited by this paper
• Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait.

  2013cited by this paper
• Parkinson disease affects peripheral sensory nerves in the pharynx.

  2013cited by this paper
• Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms

  2013cited by this paper
• The Pathophysiology of Essential Tremor and Parkinson’s Tremor

  2013cited by this paper
• Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

  2013cited by this paper
• Pathogenesis of Parkinson's disease

  2013cited by this paper
• Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.

  2013cited by this paper
• Postural Instability in Patients with Parkinson’s Disease

  2013cited by this paper
• CHAPTER 2:Molecular Pathogenesis and Pathophysiology of Parkinson’s Disease: New Targets for New Therapies

  2013cited by this paper
• The role of frontostriatal impairment in freezing of gait in Parkinson's disease

  2013cited by this paper
• Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease

  2013cited by this paper
• The prion hypothesis in Parkinson's disease: Braak to the future

  2013cited by this paper
• Energy Failure

  2013cited by this paper
• Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease

  2012cited by this paper
• The role of α-synuclein in neurodegeneration — An update

  2012cited by this paper
• Neurobiology of cognitive impairment in Parkinson’s disease

  2012cited by this paper
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

  2012influential reference
• Disruption of protein quality control in Parkinson's disease.

  2012cited by this paper
• Toward a redefinition of Parkinson's disease

  2012cited by this paper
• Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress

  2012cited by this paper
• Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

  2012cited by this paper
• Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss

  2012cited by this paper
• Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo

  2012cited by this paper
• Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease.

  2012cited by this paper
• Olfaction in Parkinson's disease and related disorders.

  2012cited by this paper
• Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

  2012cited by this paper
• Pathophysiology of bladder dysfunction in Parkinson's disease.

  2012cited by this paper
• Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease

  2012cited by this paper
• Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport

  2012cited by this paper
• A network diffusion model of disease progression in dementia.

  2012cited by this paper
• Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease

  2012cited by this paper
• The genetics and neuropathology of Parkinson’s disease

  2012cited by this paper
• Mitochondrial Quality Control and Dynamics in Parkinson's Disease

  2012cited by this paper
• Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

  2012cited by this paper
• The neuropathology of genetic Parkinson's disease

  2012cited by this paper
• Olfactory dysfunction in Parkinson disease

  2012cited by this paper
• Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

  2012cited by this paper
• Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

  2012cited by this paper
• The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders

  2012cited by this paper
• Parkinson Disease: The Enteric Nervous System Spills its Guts

  2012cited by this paper
• A mitochondrial etiology of Alzheimer and Parkinson disease.

  2012cited by this paper
• Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

  2012cited by this paper
• Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease

  2012cited by this paper
• Update on Genetics of Parkinsonism

  2012cited by this paper
• α-Synuclein and Neuronal Cell Death

  2012cited by this paper
• Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration

  2012cited by this paper
• Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals

  2012cited by this paper
• Neurodegeneration as a consequence of failed mitochondrial maintenance

  2012cited by this paper
• Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

  2012cited by this paper
• Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia

  2012cited by this paper
• Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?

  2012cited by this paper
• Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies

  2012cited by this paper
• Lewy pathology and neurodegeneration in premotor Parkinson's disease

  2012cited by this paper
• Spinal cord lesions in sporadic Parkinson’s disease

  2012cited by this paper
• Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond

  2012cited by this paper
• Genetics of Parkinson disease and other movement disorders.

  2012cited by this paper
• Clinical subtypes of Parkinson's disease

  2011cited by this paper
• Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edition

  2011cited by this paper
• Milestones in PD genetics

  2011cited by this paper
• Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease

  2011cited by this paper
• Past, Present, and Future of the Pathophysiological Model of the Basal Ganglia

  2011cited by this paper
• Milestones in Parkinson's disease—Clinical and pathologic features

  2011cited by this paper
• P145 Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT SPECT

  2011cited by this paper
• Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders

  2011cited by this paper
• Correlation between Progressive Changes in Piriform Cortex and Olfactory Performance in Early Parkinson’s Disease

  2011cited by this paper
• Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.

  2011cited by this paper
• Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor

  2011cited by this paper
• Topographical Organization of the Pedunculopontine Nucleus

  2011cited by this paper
• Etiology and pathogenesis of Parkinson's disease

  2011cited by this paper
• The relevance of iron in the pathogenesis of Parkinson’s disease

  2011cited by this paper
• The serotonergic system in Parkinson's disease.

  2011cited by this paper
• Mitochondrial Contribution to Parkinson's Disease Pathogenesis

  2011cited by this paper
• Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

  2011cited by this paper
• Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects

  2011cited by this paper
• Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.

  2011cited by this paper
• Mitochondria: The Next (Neurode)Generation

  2011cited by this paper
• Milestones in research on the pathophysiology of Parkinson's disease

  2011influential reference
• Neuropathology underlying clinical variability in patients with synucleinopathies

  2011cited by this paper
• A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials

  2011cited by this paper
• Parkinson disease

  2011cited by this paper

• Delayed feedback and sensitivity analysis for oscillations in Parkinson's disease

  2026cites this paper
• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• Convention vs. innovation III: The promise of stem cell therapy in Parkinson's disease remains bright (PSG debate 2024).

  2025cites this paper
• Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy

  2025cites this paper
• Possible regulatory mechanisms of typical and atypical absence seizures through an equivalent projection from the subthalamic nucleus to the cortex: Evidence in a computational model.

  2025cites this paper
• MPMB-DR: Meta-path Integration of Multi-source Biological Information for Drug Repositioning

  2025cites this paper
• Nuclear Medicine Imaging Biomarkers in Parkinson’s Disease: Past, Present, and Future Directions

  2025cites this paper
• Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy

  2024cites this paper
• In situ stoichiometry amounts of p62 and poly-ubiquitin exceed the increase of alpha-synuclein during degeneration of catecholamine cells induced by autophagy inhibition in vitro

  2024cites this paper
• Peripheral α-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder.

  2023cites this paper
• Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease.

  2023cites this paper
• What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson’s Disease?

  2022cites this paper
• Extraction optimization of anti-Parkinson’s medication L-DOPA and bioactive compounds from Mucuna atropurpurea (Roxb.) Wight & Arn. with biomedical potential: RSM based desirability function approach

  2022cites this paper
• The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease

  2022cites this paper
• HSF1 and Its Role in Huntington's Disease Pathology.

  2022cites this paper
• Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease

  2022cites this paper
• Simulation study on the physicochemical properties of Fe3O4 nanoparticles as drug delivery vehicles for dopamine replacement therapy of Parkinson’s Disease

  2022cites this paper
• The Influence of ADORA2A on Levodopa-Induced Dyskinesia

  2022cites this paper
• Molecular aspects of neurodegeneration and classification of neurological disorders

  2021cites this paper
• Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy

  2021cites this paper
• Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease

  2021cites this paper
• Influence of Dominance on Human Brain Activity During Voluntary Movement in Parkinson’s Disease

  2021cites this paper
• Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease

  2021cites this paper
• Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease.

  2021cites this paper
• Molecular characteristics of porcine alpha-synuclein splicing variants.

  2020cites this paper
• Protein interaction studies for understanding the tremor pathway in Parkinson's disease.

  2020cites this paper
• Criticality as a measure of developing proteinopathy in engineered human neural networks

  2020cites this paper
• Akinetic rigid symptoms are associated with decline in a cortical motor network in Parkinson’s disease

  2020cites this paper
• Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability

  2020cites this paper
• Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review

  2020cites this paper
• Mood in Parkinson's disease: From early‐ to late‐stage disease

  2020cites this paper
• Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists

  2020cites this paper
• Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates.

  2019cites this paper
• Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures.

  2019cites this paper
• A High-Intensity Exercise Boot Camp for Persons With Parkinson Disease: A Phase II, Pragmatic, Randomized Clinical Trial of Feasibility, Safety, Signal of Efficacy, and Disease Mechanisms

  2019cites this paper
• PET/CT in Brain Disorders

  2019influential citation
• [18F]FDG-PET/CT in Movement Disorders

  2019cites this paper
• Neurochemical Aspects of Neurological Disorders

  2019cites this paper
• CWD in Norway – A State of Emergency for the Future of Cervids (Phase II)

  2019cites this paper
• Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management.

  2019cites this paper
• Nigrostriatal dopamine transporter availability in early Parkinson's disease

  2018cites this paper
• Functional Connectivity Changes of Key Regions for Motor Initiation in Parkinson’s Disease

  2018cites this paper
• Functional imaging correlates of akinesia in Parkinson's disease: Still open issues

  2018cites this paper
• BAYESIAN BASED SEMIPARAMETRIC MULTIDIMENSIONAL APPROACHES TO ANALYSIS PARKINSON'S DISEASE

  2018cites this paper
• Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

  2018cites this paper
• Posterior limb of the internal capsule predicts poor quality of life in patients with Parkinson’s disease: connectometry approach

  2018cites this paper
• Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens

  2018influential citation
• Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies

  2018cites this paper
• The Effects of Transcranial Pulsed Electromagnetic Field stimulation on quality of life in Parkinson ’ s Disease

  2018cites this paper
• Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease

  2018cites this paper
• Age-dependent elevations of oligomeric and phosphorylated alpha-synuclein synchronously occurs in the brain and gastrointestinal tract of cynomolgus monkeys.

  2018cites this paper
• Combustion‐derived nanoparticles, the neuroenteric system, cervical vagus, hyperphosphorylated alpha synuclein and tau in young Mexico City residents

  2017cites this paper
• Imaging Parkinson’s disease below the neck

  2017cites this paper
• Neuroprotective Effect of Ayurvedic Preparations and Natural Products on Parkinson's Disease

  2017cites this paper
• In vivo imaging markers for the characterization of molecular changes in Parkinson and Huntington's disease

  2017cites this paper
• Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016)

  2017cites this paper
• A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies

  2017cites this paper
• Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?

  2017cites this paper
• The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders

  2016cites this paper
• THE EFFECT OF 3 DIFFERENT TRAINING PATTERNS ON THE MUSCLE STRENGTH OF PARKINSONION RATS INDUCED BY 6-HYDROXYDOPAMINE

  2016cites this paper
• Vasodegenerative disease: Lessons from the nervous system

  2016cites this paper
• L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.

  2016cites this paper
• SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model

  2016cites this paper
• HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases

  2016cites this paper
• Imaging Systemic Dysfunction in Parkinson’s Disease

  2016cites this paper
• ER stress in Parkinson’s disease

  2016cites this paper
• Parkinson’s disease: a review of non-motor symptoms

  2015cites this paper
• Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice

  2015cites this paper
• Megacities air pollution problems: Mexico City Metropolitan Area critical issues on the central nervous system pediatric impact.

  2015influential citation
• The Intestinal Barrier in Air Pollution-Associated Neural Invol vement in Mexico City Residents: Mind the Gut, the Evolution of a Chan ging Paradigm Relevant to Parkinson Disease Risk

  2015cites this paper
• Chapter Four - Development of LRRK2 Kinase Inhibitors for Parkinson's Disease

  2014cites this paper
• Alternative therapies for Morbus Parkinson: Effects of tactile stimulation in a rodent model of Parkinsons disease and induced pluripotent stem cells as a new source for neurotransplantation - therapy

  2014cites this paper
• Neurobiology and neuroanatomy of psychiatric symptoms in parkinsonism.

  2013cites this paper
• Population Therapeutics & Clinical Pharmacology

  year unknowncites this paper